Nutt D J, Lister R G
Laboratory of Clinical Studies, NIAAA, Bethesda, MD 20892.
Pharmacol Biochem Behav. 1988 Nov;31(3):751-5. doi: 10.1016/0091-3057(88)90260-2.
The ability of various benzodiazepine receptor ligands to antagonize the anticonvulsant action of ethanol was investigated using intravenous infusion of the GABA antagonist bicuculline. The partial inverse agonists FG 7142, RO 15-4513 and RO 15-3505 produced dose-related reductions in seizure threshold. These compounds also partially reversed the anticonvulsant action of ethanol. However, the magnitude of the effects in each case was only equivalent to the reduction in seizure threshold caused by each compound when administered alone. This is the proconvulsant effect of each compound merely subtracted from the anticonvulsant effect of ethanol. ZK 93426, a benzodiazepine receptor antagonist which alone failed to alter seizure threshold, did not affect the anticonvulsant action of ethanol. Both RO 15-4513 and RO 15-3505 also lowered the seizure threshold of barbiturate-treated mice, again in a subtractive fashion. The ability of RO 15-4513 and other inverse agonists to antagonize the anticonvulsant effect of ethanol appears to result from their intrinsic proconvulsant properties.
使用静脉注射γ-氨基丁酸(GABA)拮抗剂荷包牡丹碱,研究了各种苯二氮䓬受体配体拮抗乙醇抗惊厥作用的能力。部分反向激动剂FG 7142、RO 15 - 4513和RO 15 - 3505使癫痫发作阈值呈剂量依赖性降低。这些化合物还部分逆转了乙醇的抗惊厥作用。然而,每种情况下的效应大小仅相当于每种化合物单独给药时引起的癫痫发作阈值降低。这仅仅是从乙醇的抗惊厥作用中减去了每种化合物的促惊厥作用。苯二氮䓬受体拮抗剂ZK 93426单独使用时未能改变癫痫发作阈值,也不影响乙醇的抗惊厥作用。RO 15 - 4513和RO 15 - 3505同样以相减的方式降低了巴比妥酸盐处理小鼠的癫痫发作阈值。RO 15 - 4513和其他反向激动剂拮抗乙醇抗惊厥作用的能力似乎源于它们固有的促惊厥特性。